2600 KELLY ROAD, WARRINGTON, PA
Departure of President and CEO Jed Latkin at Windtree Therapeutics
News, Securities Holder Rights or Indentures
News, Material Contracts
Changes in Board, Management or Compensation
Shareholder votes
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Annual Report to Security Holders
Notice of Late Filing for Annual Report
Q3
Notice of Late Filing for Quarterly Report
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Effectiveness Notice
Amended Registration Statement for Securities
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload